<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00046670</url>
  </required_header>
  <id_info>
    <org_study_id>1191</org_study_id>
    <secondary_id>R01HL071515</secondary_id>
    <nct_id>NCT00046670</nct_id>
  </id_info>
  <brief_title>Sleep Disordered Breathing, APOE, and Lipid Metabolism</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Stanford University</source>
  <brief_summary>
    <textblock>
      To examine the relationship between obstructive sleep apnea and lipid metabolism.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      BACKGROUND:&#xD;
&#xD;
      Recent findings suggest interrelationships between obstructive sleep apnea, lipid metabolism,&#xD;
      and neurodegeneration. Apolipoprotein E epsilon4 (APOE e4), a genetic marker linked to&#xD;
      increased cardiovascular disease (CVD) risk and Alzheimer's disease (AD), is associated with&#xD;
      a two fold increased risk of sleep disordered breathing (SDB), and an increase in severity of&#xD;
      apnea symptoms. Preliminary data suggest that this association is stronger between the ages&#xD;
      of 50 and 65. Other experiments suggest dysregulated leptin levels in obstructive sleep apnea&#xD;
      (OSA). Taken together, these findings suggest common pathophysiological mechanisms involving&#xD;
      dysregulated lipid metabolism in OSA. An understanding of these mechanisms is essential for&#xD;
      the prevention and treatment of SDB.&#xD;
&#xD;
      DESIGN NARRATIVE:&#xD;
&#xD;
      Using case/control and family designs, the study: 1) extends the finding that apolipoprotein&#xD;
      E epsilon4 (APOE e4) increases the risk of sleep apnea in the general population; 2) examines&#xD;
      if polymorphisms in other genes regulating lipid levels are associated with sleep apnea; 3)&#xD;
      studies the relationship between lipid regulatory gene polymorphisms, lipid profile (LDL-&#xD;
      cholesterol, HDL-cholesterol, triglycerides), plasma leptin (and other lipid regulatory&#xD;
      hormones), and sleep apnea levels.&#xD;
&#xD;
      T&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2002</start_date>
  <completion_date type="Actual">April 2007</completion_date>
  <primary_completion_date type="Actual">April 2007</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <condition>Sleep Apnea Syndromes</condition>
  <condition>Lung Diseases</condition>
  <eligibility>
    <criteria>
      <textblock>
        No eligibility criteria&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Emmanuel Mignot</last_name>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <reference>
    <citation>Lin L, Finn L, Zhang J, Young T, Mignot E. Angiotensin-converting enzyme, sleep-disordered breathing, and hypertension. Am J Respir Crit Care Med. 2004 Dec 15;170(12):1349-53. Epub 2004 Sep 24.</citation>
    <PMID>15447944</PMID>
  </reference>
  <reference>
    <citation>Gottlieb DJ, DeStefano AL, Foley DJ, Mignot E, Redline S, Givelber RJ, Young T. APOE epsilon4 is associated with obstructive sleep apnea/hypopnea: the Sleep Heart Health Study. Neurology. 2004 Aug 24;63(4):664-8.</citation>
    <PMID>15326239</PMID>
  </reference>
  <reference>
    <citation>Taheri S, Lin L, Austin D, Young T, Mignot E. Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Med. 2004 Dec;1(3):e62. Epub 2004 Dec 7.</citation>
    <PMID>15602591</PMID>
  </reference>
  <verification_date>March 2014</verification_date>
  <study_first_submitted>September 30, 2002</study_first_submitted>
  <study_first_submitted_qc>September 30, 2002</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 1, 2002</study_first_posted>
  <last_update_submitted>March 4, 2014</last_update_submitted>
  <last_update_submitted_qc>March 4, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 5, 2014</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Lung Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

